| Tag | Content |
|---|
EnhancerAtlas ID | HS051-01762 |
Organism | Homo sapiens |
Tissue/cell | Fetal_thymus |
Coordinate | chr1:161500460-161501420 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr1:161501184-161501202 | CCTCCCTTCCTTCCTTTG | - | 6.66 | | EWSR1-FLI1 | MA0149.1 | chr1:161501180-161501198 | CTTTCCTCCCTTCCTTCC | - | 9.01 | | KLF5 | MA0599.1 | chr1:161500746-161500756 | GGGGCGGGGC | - | 6.02 | | ZNF263 | MA0528.1 | chr1:161501180-161501201 | CTTTCCTCCCTTCCTTCCTTT | - | 6.12 |
|
| | Number of super-enhancer constituents: 16 | ID | Coordinate | Tissue/cell |
| SE_04668 | chr1:161498891-161504488 | Brain_Anterior_Caudate | | SE_07207 | chr1:161498982-161504752 | Brain_Hippocampus_Middle_150 | | SE_09773 | chr1:161497742-161504419 | CD14 | | SE_12218 | chr1:161499699-161501650 | CD3 | | SE_12655 | chr1:161500190-161500727 | CD34_adult | | SE_12655 | chr1:161501069-161501187 | CD34_adult | | SE_12761 | chr1:161500307-161500650 | CD34_fetal | | SE_12761 | chr1:161501118-161501331 | CD34_fetal | | SE_13488 | chr1:161498207-161504412 | CD34_Primary_RO01536 | | SE_15045 | chr1:161497584-161504740 | CD4_Memory_Primary_7pool | | SE_16658 | chr1:161499691-161501924 | CD4_Naive_Primary_8pool | | SE_20033 | chr1:161499313-161501693 | CD56 | | SE_20739 | chr1:161496350-161504511 | CD8_Memory_7pool | | SE_22428 | chr1:161499172-161501885 | CD8_primiary | | SE_39937 | chr1:161499262-161501453 | K562 | | SE_53676 | chr1:161499218-161501513 | Spleen |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr1 | 161500960 | 161501200 | | chr1 | 161500608 | 161500899 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I161528 | chr1 | 161498591 | 161503308 |
|
Enhancer Sequence | GGGGTCGAGC CATGTCAAGG TAGACCCTGT GTCGGCCCGT CTCCCTCGGA TCCTCCGCAC 60
CAATCACTGT TGCTGAATCC GACACCCGGC GGATCCAGTG CGGAGTCTCG AACAGCTGCG 120
GAGCTGGGAG CTACGGGACA TGAAGAGAGC GGGGTGGAAG AGAAGACGGC GGAGGAAAAT 180
CCCCCGGCGA TGCTCAACTG CGGCTTTCTC TCTCGGCTGT GAGCCGGCTC CGCCCTCCAG 240
CTTCCAGAGC CGGTGGCTTC TGCGTTCACC GCCCCGCGCC GTTTGCGGGG CGGGGCTGAT 300
TCATAAGAAT CGGTTCTCAC CAATGGAGGG CTTAGCTTGT TTAACCTCAG GATCATAAAC 360
AAAAGACACT GCTAGAACGG TCGGGAAAGT CATACGCTTT GCTTATCTTA TATATAGATA 420
TCTAAAACTC CAAACCGGGT ACGCGTTGGT GGTATAGTGG TGAGCATAGC TGCCTTCCAA 480
GCAGTTGACC CGGGTTCGAT TCCCGGCCAA CGCAAGGGTT TTTGTCTTTC CTTCTACGAA 540
AAACCTTTCT CAGTCAGAAC CTATAACGCG CTGTGTATCC GTTTTACGCC TCAACGAAGT 600
ATCCGTTTTA CGCTTCAACG AAACTGCAGC AATACCTCAC TTTCCGTACT CGCTTCCTGT 660
CTTTCCCCTG GCCTCTTTCT AAACCCAGGC GTTTTTTGAA GGGATTAAAT TCTGATGGTT 720
CTTTCCTCCC TTCCTTCCTT TGTAAACTTC CAACTCTTGA GGAATCTTTG GGATCATTTC 780
AATCCTGGGA TGAGTCTTAG CTTCAGAAAG GGGCTCTTGT GTCTTCACTT GCGAGGTTCA 840
TTCGCTAGCC ACGCACTATT GAGCACGTGA ACTTGGCTAG TTTCTCTAAG AAACTGCATT 900
TTCAAATTTA GTCTTAGTAA ATAAATCAAT TGAAATAAAA TTAATAAGTG AAAATTTTAA 960
|
